Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001067861 | SCV001232942 | pathogenic | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1578 of the USH2A protein (p.Arg1578Cys). This variant is present in population databases (rs201529124, gnomAD 0.008%). This missense change has been observed in individual(s) with Usher syndrome or retinitis pigmentosa (PMID: 22135276, 24618324, 29142287, 29625443). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 861348). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on USH2A protein function. For these reasons, this variant has been classified as Pathogenic. |
Ocular Genomics Institute, |
RCV001376322 | SCV001573426 | likely pathogenic | Retinitis pigmentosa 39 | 2021-04-08 | criteria provided, single submitter | research | The USH2A c.4732C>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PP3, PP1, PM3-S. Based on this evidence we have classified this variant as Likely Pathogenic. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002282450 | SCV002572153 | pathogenic | Usher syndrome | 2022-08-18 | criteria provided, single submitter | clinical testing | Variant summary: USH2A c.4732C>T (p.Arg1578Cys) results in a non-conservative amino acid change located in the laminin G domain (IPR001791) of the encoded protein sequence. Three out of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251166 control chromosomes (gnomAD). c.4732C>T has been reported in the literature in multiple biallelic individuals affected with Usher Syndrome and/or retinitis pigmentosa (e.g. Le Quesne Stabej_2012, Jinda_2014, Pierrache_2016, Eandi_2017, Sun_2018, Karali_2019, Mansard_2021, Bahena_2022). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. All classified the variant as pathogenic (n=1) or likely pathogenic (n=2). Based on the evidence outlined above, the variant was classified as pathogenic. |
Genome- |
RCV001376322 | SCV004182205 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455294 | SCV004182208 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001376322 | SCV004208143 | pathogenic | Retinitis pigmentosa 39 | 2023-10-21 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001067861 | SCV001924929 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001067861 | SCV001971959 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
OMIM | RCV001376322 | SCV003841033 | pathogenic | Retinitis pigmentosa 39 | 2023-04-17 | no assertion criteria provided | literature only |